This study is being done to see if the study drug, called BI 764198, may help people with your type of kidney disease called "FSGS" or focal segmental glomerulosclerosis. If you join this study, you may receive the study drug being tested BI 764198, or a placebo.
You will be asked to take a pill each day for 12 weeks. At each study visit we will take your blood pressure, obtain blood and urine samples, and perform a physical exam. You will have an eye exam at the beginning and end of the study. We would also like for you to keep a study drug diary to write down how you are feeling.
You may receive up to $1,425 for your participation, Gas reimbursement
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
Clinical Research Unit
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA
Vimal Derebail
Medicine-Nephrology
Clinical or Medical
Interventional
Kidneys and Liver
23-0530
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
